Linkedin
Facebook
Email
moreRSM conducted the financial due diligence for TechLife Capital—a growth capital fund specializing in healthcare and new technologies—as part of its equity investment in Quinten, a company recognized for its expertise in artificial intelligence and data science, particularly in the healthcare and pharmaceutical sectors.
Through this engagement, RSM’s Corporate Finance team further strengthens its positioning as an advisor to investment funds in their strategic acquisitions involving cutting-edge technologies (AI, new tech, deep tech).
TechLife Capital and MACSF Invest in Quinten
Alongside minority investor MACSF Group, TechLife Capital has invested €14 million in growth capital to support the development of this French champion with the ambition of turning it into a major European player in the field.
This fundraising will allow Quinten to prioritize the development of two SaaS platforms aimed at major players in the healthcare sector:
- Quinten Health: Real-world disease modeling to optimize drug development and assessment
- PharmIA: Analysis of hospital prescriptions to assist pharmacists and reduce medication-related risks (iatrogenic events)
Founded nearly 15 years ago, the company is transitioning from a consulting model to a SaaS platform model. Quinten currently employs 80 people, including 60 data scientists and 20 developers.
Quinten represents TechLife Capital’s sixth investment, following: XPATH (cancer diagnostics), FLASH THERAPEUTICS (biotech drug production using lentiviral vectors), MYDATA TRUST (management of patient data from clinical trials in biotechnology), MITEM PHARMA (a pharmaceutical laboratory dedicated to Essential Medicines of Major Therapeutic Interest), MAXXING (SaaS-based customer loyalty software)
The RSM team
The RSM team involved was composed of Eric Fougedoire, Charles Tiran et Loïc Van Cauwelaert.
TechLife Capital is a growth capital fund focused on the healthcare and new technology sectors. It invests in companies—ranging from fast-growing SMEs to global groups—operating in high-potential verticals such as health data management, biotechnology, cancer diagnostics, and essential medicines. The fund supports these companies in their growth and transformation throughout Europe.
TechLife Capital SAS is an asset management company authorized by the French Financial Markets Authority (AMF). It has been awarded the Tibi Label – Financing Innovation – by the French Ministry of Economy.
RSM is the 6th largest global network of audit, consulting, and accounting firms, operating in more than 120 countries and comprising over 53,000 professionals and partners.
In France, RSM is a key player in audit, consulting, and accounting services. The firm has a strong regional presence, with offices in Paris, Lyon-Chambéry-Grenoble, Montpellier-Nîmes, Nantes-Laval, Strasbourg-Colmar, Réunion, and Mayotte. Today, the firm includes more than 1,250 professionals across the country and continues to expand its regional footprint. RSM’s multidisciplinary offering is structured around five main service lines: Audit, Accounting, Consulting, HR & Payroll, and Legal & Tax Advisory.
RSM’s Corporate Finance division supports companies and their executives, investment funds, and shareholders—both in France and internationally—to secure and optimize financial decision-making. The team includes 20 professionals based in Paris and regional offices, including 3 partners. RSM Corporate Finance offers services in Transaction Services, Valuation & Complex Financial Modelling, Capital Operations, and Restructuring.
